An Update on our Russian operations

WEBWIRE



The following message was shared with Coca-Cola HBC employees regarding our operations in Russia


Dear colleagues,


I write to update you on the future shape of our business in Russia.


As we indicated in our Q1 trading update, we are making significant changes to our Russian operations in response to the ongoing geopolitical crisis.


In close alignment with The Coca-Cola Company, we have stopped all production and sales of brands of The Coca-Cola Company in Russia. There are no plans to reintroduce The Coca-Cola Company brands or products in any format.


Going forward, we intend to have a much smaller operation in Russia which has been renamed Multon Partners. This will focus on the production and sale of existing local brands – Dobry, Rich and Moya Semya – and raw materials will be sourced from within the market. It will be managed and operated locally.


Over the coming months, Multon Partners will consider how best to establish itself, which may include some extensions of existing local brands, however no plans have been finalised.   


We continue to support our colleagues and their communities in Ukraine and neighbouring countries however we can; through individual donations, volunteering and the more than $18.5m donations committed by the Coca-Cola System globally.


We appreciate this is an incredibly challenging time for many of you and we want to thank you for your support during this period.


Zoran Bogdanovic,


CEO, Coca-Cola HBC


Update on COVID-19 Vaccine Availability in States/UTs


The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country. The nationwide COVID 19 vaccination started on 16th January 2021. The new phase of universalization of COVID-19 vaccination commenced from 21st June 2021. The vaccination drive has been ramped up through availability of more vaccines, advance visibility of vaccine availability to States and UTs for enabling better planning by them, and streamlining the vaccine supply chain.


As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.









VACCINE DOSES



(As on 21st July 2022)



SUPPLIED



1,93,63,12,325



BALANCE AVAILABLE





8,32,51,830




More than 193.63 crore (1,93,63,12,325) vaccine doses have been provided to States/UTs so far through Govt. of India (free of cost channel) and through direct state procurement category.


More than 8.32 Cr (8,32,51,830) balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.




****


MV


HFW/COVID Vaccine doses to States/21 July 2022/2




(Release ID: 1843289)
Visitor Counter : 681











Hong Kong – Update on cluster of Multi-drug Resistant Acinetobacter cases in Pok Oi Hospital

Update on cluster of Multi-drug Resistant Acinetobacter cases in Pok Oi Hospital

********************************************************************************


The following is issued on behalf of the Hospital Authority:



     Regarding an earlier announcement on a cluster of patients confirmed to be carriers of Multi-drug Resistant Acinetobacter (MDRA) in a medicine and geriatrics ward, the spokesperson for Pok Oi Hospital gave the following update today (July 16): 

     ​

     In accordance with the prevailing guidelines, the hospital commenced contact tracing and confirmed two more male patients (aged 59 and 66) as carriers of MDRA. The two patients are currently hospitalised under isolation and are in stable and serious condition respectively.



     The following enhanced infection control measures have continued to be implemented according to the established guidelines: 



     1. Enhanced cleaning and disinfection of the ward concerned; 

     2. Application of stringent contact precautions and enhanced hand hygiene for staff and patients; and

     3. Enhanced patient and environmental screening procedures. 



     The cases have been reported to the Hospital Authority Head Office and the Centre for Health Protection for necessary follow-up. The hospital will continue to closely monitor the situation of the ward concerned.

Hong Kong – Update on cluster of Vancomycin Resistant Enterococci cases at Queen Elizabeth Hospital

Update on cluster of Vancomycin Resistant Enterococci cases at Queen Elizabeth Hospital

*****************************************************************************************


The following is issued on behalf of the Hospital Authority:



     Regarding an earlier announcement on Vancomycin Resistant Enterococci (VRE) carrier cases, the spokesperson for Queen Elizabeth Hospital made the following update today (June 26):



     In accordance with the prevailing infection control guidelines, the hospital commenced contact tracing. One more 90-year-old male patient in the surgical ward was confirmed as VRE carrier. The patient concerned did not have clinical symptoms and had been discharged earlier.



     The ward concerned has adopted the following enhanced infection control measures:

 

  1. Enhanced patient and environmental screening procedures;
  2. Application of stringent contact precautions and enhanced hand hygiene for staff and patients; and
  3. Enhanced cleaning and disinfection of the ward concerned.




     The hospital will continue to closely monitor the situation of the ward and the patient. The case has been reported to the Hospital Authority Head Office and the Centre for Health Protection for necessary follow-up.

Hong Kong – Update on processing 2022 Employment Support Scheme applications

Update on processing 2022 Employment Support Scheme applications

****************************************************************


     A Government spokesman said today (June 20) that the 2022 Employment Support Scheme (2022 ESS) Secretariat has so far approved wage subsidies for May for about 152 000 employers, involving a total of about $10 billion for over 1.2 million employees. They represented about 86 per cent of all applications received from employers.

 

     Moreover, the Secretariat is issuing notifications to some 4 000 unsuccessful employer applicants. Reasons for rejection include employers not making the Mandatory Provident Fund (MPF) contributions for their employees, or employees not meeting the eligibility criteria for the 2022 ESS. Applicants who intend to request a review of the application results should provide the relevant MPF remittance statements for the fourth quarter of 2021 showing that they have made contributions to their relevant employees on or before February 28, 2022.

 

     For the remaining some 10 per cent of applications pending processing, the government-appointed agent is seeking supplementary information from the relevant employers or MPF trustees. The Secretariat’s target is to complete processing these cases within June. 

 

     Also, the Secretariat will, by next week, notify the first batch of employers of their final approved wage subsidies for June. They will receive the June wage subsidies within seven working days upon receiving notifications.

 

     As for self-employed persons (SEPs), the Secretariat has so far approved nearly 72 000 applications, involving a total of about $570 million. They represented about 60 per cent of all SEPs applications received. Starting from next week, notifications will be issued to around 30 000 unsuccessful SEPs applicants. Their applications were not approved mainly because of not having an eligible SEPs MPF account. The Secretariat targets to complete vetting the remaining approximately 15 000 applications within June.